William Pickering
Stock Analyst at Bernstein
(1.73)
# 3,405
Out of 5,111 analysts
31
Total ratings
50%
Success rate
-2.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $74.51 | +26.16% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $11.28 | -20.21% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $175.74 | -10.66% | 1 | Nov 3, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $95 → $88 | $52.12 | +68.84% | 5 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $9.14 | +58.64% | 2 | Oct 28, 2025 | |
| RNA Avidity Biosciences | Downgrades: Market Perform | $52 → $72 | $71.86 | +0.19% | 1 | Oct 27, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $753 → $781 | $752.62 | +3.77% | 3 | Aug 27, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $21.55 | -39.68% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $391.50 | -20.82% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $68.45 | -64.94% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $79.76 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $455.71 | - | 5 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $37 | $26.83 | +37.91% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.47 | +308.16% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $56.25 | -21.78% | 1 | Mar 21, 2023 |
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $74.51
Upside: +26.16%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $11.28
Upside: -20.21%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $175.74
Upside: -10.66%
BioMarin Pharmaceutical
Nov 3, 2025
Maintains: Outperform
Price Target: $95 → $88
Current: $52.12
Upside: +68.84%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $9.14
Upside: +58.64%
Avidity Biosciences
Oct 27, 2025
Downgrades: Market Perform
Price Target: $52 → $72
Current: $71.86
Upside: +0.19%
Regeneron Pharmaceuticals
Aug 27, 2025
Maintains: Outperform
Price Target: $753 → $781
Current: $752.62
Upside: +3.77%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $21.55
Upside: -39.68%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $391.50
Upside: -20.82%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $68.45
Upside: -64.94%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $79.76
Upside: -
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $455.71
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $26.83
Upside: +37.91%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.47
Upside: +308.16%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $56.25
Upside: -21.78%